Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 2/3 3Phase NA 1Phase 3 1

Status

Terminated 2Unknown 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3NETWORK 1INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 5

Conditions

Breast Neoplasms 3Triple Negative Breast Neoplasms 1Locally Advanced HER2-negative Breast Cancer 1

Interventions

Trastuzumab 347Paclitaxel 309Cyclophosphamide 286Docetaxel 267Carboplatin 215Capecitabine 214Letrozole 185Fulvestrant 176Doxorubicin 166Bevacizumab 136Anastrozole 120Tamoxifen 117pertuzumab 112pembrolizumab 112Epirubicin 110exemestane 107Vinorelbine 106Gemcitabine 106Albumin-Bound Paclitaxel 92Lapatinib 84130-nm albumin-bound paclitaxel 83Radiotherapy 79palbociclib 75eribulin 73Cisplatin 69pyrotinib 65Taxes 65Everolimus 55Goserelin 50Drug Therapy 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × AC protocol × Breast × Clear all
NCT03609047 2026-05-12

Appalaches

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Active not recruiting
366 enrolled
Breast

Breast Neoplasms

NCT02096588 2024-07-09

Detection and Prevention of Anthracycline-Related Cardiac Toxicity With Concurrent Simvastatin

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Terminated
34 enrolled 11 charts
Breast

Breast Neoplasms

NCT04248998 2023-01-18

BREAKFAST

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Unknown
30 enrolled
Breast

Triple Negative Breast Neoplasms

NCT01329627 2014-05-21

TAME-01

Instituto do Cancer do Estado de São Paulo

Phase 2 Terminated
12 enrolled
Breast

Locally Advanced HER2-negative Breast Cancer

NCT00849472 2014-03-04

Treatment With Pazopanib for Neoadjuvant Breast Cancer

GlaxoSmithKline

Phase 2 Completed
101 enrolled 16 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡